STOCKS TO BUY: We have identified several stocks that can potentially TRIPLE. Learn more!

Citrix Systems, Watson Pharmaceuticals: S&P Gainers

Stock quotes in this article: CTXS, ^GSPC, WPI 

NEW YORK (TheStreet) -- Citrix Systems (CTXS) and Watson Pharmaceuticals (WPI) were among the best-performing stocks in the S&P 500 on Thursday.

The S&P 500 rose 9.29 points, or 0.67%, to 1,399.98 on Thursday.

Shares of Citrix Systems gained 12.43% to $86.76. On Thursday, the stock was upgraded to outperform by FBR Securities analysts with a $100 price target after a big earnings beat.

The company reported Wednesday after the close first-quarter earnings of 59 cents a share, excluding items, up from year-earlier earnings of 50 cents. On average, analysts expected earnings of 51 cents a share.

First quarter revenue grew 20% to $589 million.

Citrix Systems trades at an estimated price-to-earnings ratio for next year of 27.37X; the average for software companies is 30.58X. For comparison, Salesforce.com (CRM) has a higher forward P/E of 74.88X.

Twenty-three of the 35 analysts who cover Citrix rated it buy. Eleven analysts gave the stock a hold rating and one rated it sell.

TheStreet Ratings gives Citrix an A- grade with a buy rating and $90.32 price target. The stock has risen 42.89% year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
TRY IT FREE
New! $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,179.85 109.67 0.73%
NASDAQ 3,452.13 28.57 0.83%
S&P 500 1,639.04 12.31 0.76%
US 10 Yr 2.171% +0.045

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs